The Honest Company
The Honest Company's revenue fell 1.9% to $371 million in fiscal 2025. Its operating margin was −5.0%, down from −1.7% a year earlier. Free cash flow was $14 million, up 1246.3%. The diluted share count rose 10.9%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on equity is net income as a share of shareholders' equity. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
What The Honest Company does
The Honest Company, founded in 2012, sells baby and personal care products. Its range covers wipes, diapers, and personal care and beauty items such as facial care, for people from babies to adults. It describes its products as cleanly formulated and sustainably designed, and it reports a single operating segment.
It sells through retail partners, in stores and on their own websites. It began selling through Target in 2014, Amazon in 2017 and Walmart in 2022, and through many other retailers across the U.S.
The company is running cost-cutting and growth programs that it calls the Transformation Initiative and Powering Honest Growth.
Its biggest risks, as it describes them
- Reaching its long-term strategy, including its cost reduction plans, may not work as planned.
- Retail customers are consolidating, and losing a significant retail or online customer would hurt it.
- It may not compete successfully in a highly competitive market.
- It may fail to win new consumers or keep existing ones at a reasonable cost.
- It may be unable to forecast revenue, margins and expenses accurately.
Income statement
The Honest Company lost money in fiscal 2025: a net loss of $16 million.
Returns on capital
Balance sheet
Five years at a glance
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 93 | 15 | 33 | 75 | 90 |
| Debt incl. finance leases | — | — | — | — | — |
| Net debt (negative means net cash) | — | — | — | — | — |
| Net debt to EBITDA | — | — | — | — | — |
| Debt to equity | — | — | — | — | — |
| Interest coverage | −20.5x | −6,222.5x | −38,909.0x | — | — |
| Current ratio | 4.4x | 3.0x | 2.8x | 3.6x | 4.0x |
| Quick ratio | 2.9x | 1.2x | 1.5x | 2.1x | 2.6x |
Cash flow
Projections
Project The Honest Company's revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.
Insider trades
Over the 12 months between November 14, 2025 and November 13, 2026, no insider bought The Honest Company shares on the open market, and 10 insiders sold $3.7 million, $2.7 million of it under trading plans set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 9, 2026 | Thomas SternweisSVP, Enterprise Dev. & Strat. | Sold plan | 25,000 | $4.70 | $117,500 | Form 4 |
| Sep 14, 2026 | Thomas SternweisSVP, Enterprise Dev. & Strat. | Sold plan | 25,000 | $5.48 | $137,000 | Form 4 |
| Aug 21, 2026 | Kunssberg Etienne vonSVP, Supply Chain | Sold plan | 4,578 | $5.01 | $22,936 | Form 4 |
| Aug 20, 2026 | Carla VernonChief Executive Officer, Director | Sold plan | 117,893 | $4.99 | $588,286 | Form 4 |
| Aug 20, 2026 | Brendan SheeheyGeneral Counsel | Sold plan | 9,664 | $4.99 | $48,223 | Form 4 |
| Aug 20, 2026 | Dorria L. BallChief People Officer | Sold plan | 6,812 | $4.99 | $33,992 | Form 4 |
| Aug 20, 2026 | Thomas SternweisSVP, Enterprise Dev. & Strat. | Sold plan | 6,403 | $4.99 | $31,951 | Form 4 |
| Aug 20, 2026 | Jonathan MayleSVP, Customer Sales | Sold plan | 6,161 | $4.99 | $30,743 | Form 4 |
| Aug 20, 2026 | Curtiss James Bruce IIIChief Fin. & Operating Officer | Sold plan | 3,129 | $4.99 | $15,614 | Form 4 |
| Aug 20, 2026 | Kunssberg Etienne vonSVP, Supply Chain | Sold plan | 2,617 | $4.99 | $13,059 | Form 4 |
| Aug 11, 2026 | Andrea TurnerDirector | Sold | 29,899 | $5.21 | $155,774 | Form 4 |
| Aug 10, 2026 | Jonathan MayleSVP, Customer Sales | Sold | 79,000 | $5.22 | $412,380 | Form 4 |
Indicators
Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.
| Indicator | FY23 | FY24 | FY25 |
|---|---|---|---|
| Piotroski F-score | — | — | — |
| Rule of 40 | 14.9% | 10.1% | 1.8% |
| Altman Z'' | −4.11 | 0.02 | −0.19 |
| Accruals ratio | −26.5% | −3.4% | −13.0% |
The nine F-score tests
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Fail | Fail | Fail |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Pass | Pass | Fail |
| Cash from operations exceeds net income | Pass | Pass | Pass |
| Debt fell relative to assets | — | — | — |
| Current ratio rose | Fail | Pass | Pass |
| Share count didn't rise | Fail | Fail | Fail |
| Gross margin rose | Fail | Pass | Fail |
| Revenue rose relative to assets | Pass | Pass | Fail |
| F-score | — | — | — |
Compare
Put The Honest Company side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| The Honest Company | FY25 | −1.9% | −5.0% | 3.7% | — | — | — | |
| Nature's Sunshine Products | FY25 | 5.7% | 5.2% | 6.0% | 23.6% | −2.4x | 7 | Compare |
| USANA Health Sciences | FY25 | 8.3% | 4.0% | 0.9% | — | — | — | Compare |
| Niagen Bioscience | FY25 | 29.9% | 12.6% | — | — | −3.8x | 6 | Compare |
| Nu Skin | FY25 | −14.3% | 4.4% | 3.1% | 6.5% | −0.1x | 7 | Compare |
7 years of figures
| Fiscal year | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 236 | 300 | 319 | 314 | 344 | 378 | 371 |
| Revenue growth | — | 27.6% | 6.0% | −1.6% | 9.8% | 9.9% | −1.9% |
| Gross profit | 76 | 108 | 109 | 92 | 100 | 145 | 124 |
| Research and development | 5 | 6 | 8 | 7 | 6 | 7 | 7 |
| Operating income | −32 | −14 | −37 | −50 | −39 | −6 | −18 |
| Net income | −31 | −14 | −39 | −49 | −39 | −6 | −16 |
| Diluted EPS (US$) | −0.92 | −0.43 | −0.43 | −0.53 | −0.42 | −0.06 | −0.14 |
| Diluted shares (millions) | 34 | 34 | 71 | 92 | 94 | 100 | 111 |
| Cash flow | |||||||
| Cash from operations | −20 | −12 | −38 | −76 | 19 | 2 | 15 |
| Capital expenditure | 1 | 0 | 0 | 2 | 2 | 0 | 2 |
| Free cash flow | −21 | −12 | −38 | −78 | 18 | 1 | 14 |
| Dividends paid | 0 | 0 | 35 | 0 | 0 | 0 | 0 |
| Share buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-based compensation | 8 | 8 | 17 | 15 | 16 | 16 | 10 |
| Balance sheet at fiscal year end | |||||||
| Cash and short-term investments | 14 | 64 | 93 | 15 | 33 | 75 | 90 |
| Debt incl. finance leases | — | — | — | — | — | — | — |
| Total assets | — | 241 | 273 | 241 | 202 | 247 | 225 |
| Total liabilities | — | 101 | 94 | 94 | 78 | 73 | 56 |
| Shareholders' equity | −230 | −237 | 179 | 146 | 123 | 174 | 170 |
| Margins and ratios | |||||||
| Gross margin | 32.2% | 35.9% | 34.3% | 29.4% | 29.2% | 38.2% | 33.3% |
| Operating margin | −13.3% | −4.5% | −11.6% | −15.9% | −11.3% | −1.7% | −5.0% |
| Net margin | −13.2% | −4.8% | −12.1% | −15.6% | −11.4% | −1.6% | −4.2% |
| Free cash flow margin | −8.8% | −4.1% | −12.0% | −24.8% | 5.1% | 0.3% | 3.7% |
| Rule of 40 (growth + FCF margin) | — | 23.5% | −6.0% | −26.4% | 14.9% | 10.1% | 1.8% |
| Return on capital | — | — | — | — | — | — | — |
| Return on equity | — | — | — | −30.1% | −29.1% | −4.1% | −9.1% |
| Return on assets | — | — | −15.1% | −19.1% | −17.8% | −2.7% | −6.6% |
| Net debt to EBITDA | — | — | — | — | — | — | — |